Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

Marimed (MRMD) Dividends Paid - Common (2017 - 2025)

Marimed (MRMD) has disclosed Dividends Paid - Common for 9 consecutive years, with $34000.0 as the latest value for Q3 2025.

  • On a quarterly basis, Dividends Paid - Common fell 8.11% to $34000.0 in Q3 2025 year-over-year; TTM through Sep 2025 was $134000.0, a 10.67% decrease, with the full-year FY2024 number at $139000.0, down 12.03% from a year prior.
  • Dividends Paid - Common was $34000.0 for Q3 2025 at Marimed, up from $23000.0 in the prior quarter.
  • In the past five years, Dividends Paid - Common ranged from a high of $1.8 million in Q4 2022 to a low of -$301000.0 in Q4 2021.
  • A 5-year average of $126947.4 and a median of $45000.0 in 2024 define the central range for Dividends Paid - Common.
  • Peak YoY movement for Dividends Paid - Common: crashed 478.03% in 2021, then skyrocketed 690.03% in 2022.
  • Marimed's Dividends Paid - Common stood at -$301000.0 in 2021, then surged by 690.03% to $1.8 million in 2022, then plummeted by 98.31% to $30000.0 in 2023, then tumbled by 36.67% to $19000.0 in 2024, then surged by 78.95% to $34000.0 in 2025.
  • Per Business Quant, the three most recent readings for MRMD's Dividends Paid - Common are $34000.0 (Q3 2025), $23000.0 (Q2 2025), and $58000.0 (Q1 2025).